Atlas Trials

Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of ≤6 Months

Clinical trial NCT05046327 · WITHDRAWN

Trial details

NCT number
NCT05046327
Sponsor
Sobi, Inc.
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Immune Thrombocytopenia
Start date
2021-10-14
Primary completion
2024-04-06
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.